Bios Partners
PE / VC
2020
$272 M
Redwood City, California, United States
Profile
Bios Partners is a venture capital firm based in Fort Worth, Texas, founded in 2014 by Aaron Fletcher and Leslie W. Kreis, Jr. The firm focuses on identifying advanced biotech opportunities in overlooked and under-invested markets across the United States. With a team of 10 professionals, Bios Partners leverages its combined 80 years of experience in hedge funds, private equity, clinical drug development, and public pharma/biotech analysis to cultivate and bring innovative companies to market.
The firm invests in the healthcare and life sciences sectors, targeting seed-stage to later-stage companies. Bios Partners is particularly interested in disrupting geographic favoritism by investing in compelling science across the Central US. The firm manages several funds, including Bios Fund II NT, LP, with an AUM of $5 million. Their investment strategy includes a focus on the New England, Southeast, South, and West Coast regions of the United States.
Notable investments by Bios Partners include Actuate Therapeutics - drug discovery, Cognition Therapeutics - neurodegenerative disease treatment, Encore Vision - ophthalmic pharmaceuticals, I-Lumen Scientific - medical devices, and Immusoft - cell therapy. These investments highlight the firm's commitment to advancing healthcare innovations.
Industry
Bios Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Bios Fund II NT, LP
|
Private Equity (PE)
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
HealthTech
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$5 M
|
October 2018
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.